Patents by Inventor Neville R. Kallenbach

Neville R. Kallenbach has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20150337011
    Abstract: Novel peptide compounds and pharmaceutical compositions thereof are disclosed that have a formula represented by the following formula (I) wherein L1, L2, L3, Z, R1, R2, R4 and R5 are as described herein. The compounds demonstrate antimicrobial activity and may be prepared as pharmaceutical compositions and used for the prevention and treatment of a variety of conditions in mammals including humans where microbial invasion is involved. The present peptides are particularly valuable as their effect is rapid, broad in spectrum and mostly indifferent to resistance provided by standard antibiotics.
    Type: Application
    Filed: July 31, 2015
    Publication date: November 26, 2015
    Inventors: Neville R. Kallenbach, Filbert Totsingan
  • Patent number: 6045224
    Abstract: Eyewear which provides a visual stimulation to the wearer while permitting the wearer to maintain a degree of normal sight. The eyewear may include a frame securing a first viewing zone which is responsive to an external signal for modulation of a visual characteristic thereof and a second viewing zone which permits the wearer to maintain a degree of normal sight through that zone. Alternatively, a single zone is responsive to an external signal while nevertheless permitting the wearer to maintain an degree of normal sight.
    Type: Grant
    Filed: April 29, 1997
    Date of Patent: April 4, 2000
    Inventors: Neville R. Kallenbach, Victor N. Morozov
  • Patent number: 5460960
    Abstract: Process for producing an immunoproximity catalyst for a chemical reaction. Chemical reactions in which the immunoproximity catalyst can be used are also disclosed.
    Type: Grant
    Filed: January 27, 1994
    Date of Patent: October 24, 1995
    Assignee: IGEN, Inc.
    Inventors: Peter S. Kim, Neville R. Kallenbach
  • Patent number: 5401641
    Abstract: Process for producing an antibody catalyst for a chemical reaction. Chemical reactions in which the antibody catalyst can be used are also disclosed.
    Type: Grant
    Filed: June 7, 1993
    Date of Patent: March 28, 1995
    Assignee: IGEN, Inc
    Inventors: Peter S. Kim, Neville R. Kallenbach
  • Patent number: 5386020
    Abstract: The invention discloses an n-connected closed covalent three-dimensional structure of oligonucleotides, n being at least 3, and methods for making and using same.
    Type: Grant
    Filed: January 10, 1991
    Date of Patent: January 31, 1995
    Assignee: New York University
    Inventors: Nadrian C. Seeman, Junghuei Chen, Neville R. Kallenbach
  • Patent number: 4963355
    Abstract: Process for producing an antibody catalyst for a chemical reaction. Chemical reactions in which the antibody catalyst can be used are also disclosed.
    Type: Grant
    Filed: June 19, 1987
    Date of Patent: October 16, 1990
    Assignee: Igen, Inc.
    Inventors: Peter S. Kim, Neville R. Kallenbach
  • Patent number: 4880512
    Abstract: A novel irradiation process and products made thereby. The process treats biological media such as blood fractions, genetically engineered protein products and vaccine preparations. The process photolyzes nucleic acids in preference to proteins in the media, e.g., it inactivates DNA- or RNA-containing pathogens while leaving the proteins substantially intact or functional. In general, the process comprises irradiating the medium with pulsed light of wavelength and flux selected so that (1) the nucleic acids in their ground state absorb radiation and thereby rise to an excited state or states, (2) the nucleic acids in their excited states absorb radiation and thereby rise to higher energy states and undergo photolysis, and (3) the proteins in their ground or their excited states do not absorb sufficient radiation to undergo substantial photolysis.
    Type: Grant
    Filed: October 14, 1988
    Date of Patent: November 14, 1989
    Assignee: Kollmorgen Corporation
    Inventors: Paul A. Cornelius, Robin M. Hochstrasser, Neville R. Kallenbach, Harvey Rubin, George J. Todaro
  • Patent number: 4792446
    Abstract: Process for producing an antibody catalyst for a chemical reaction. Chemical reactions in which the antibody catalyst can be used are also disclosed.
    Type: Grant
    Filed: June 23, 1986
    Date of Patent: December 20, 1988
    Assignee: Igen, Inc.
    Inventors: Peter S. Kim, Neville R. Kallenbach